Indeed, PARP hyperactivation was shown to decrease activation of the NAD+‐ SIRT1‐PGC1α axis in cells from patients with Xeroderma Pigmentosum group A (XPA), a human disorder characterized by defective NER. This evidence concerns the gene PARP1 and xeroderma pigmentosum group A.